Recommendations for exercise testing in chronic heart failure patients

European Heart Journal

Volumn 22, Issue 1, 2001, Pages 37-45

  Bjornstad H ^a   Cohen Solal, A ^a   Dubach, P ^a   Fioretti, P M ^a   Giannuzzi, P ^a   Hambrecht, R ^a   Hellemans, I ^a   McGee, H ^a   Mendes, M ^a   Perk, J ^a   Saner, H ^a   Verres, G ^a   Brutsaert, D L ^a   Cleland, J G F ^a   Dresler, H ^a   Erhardt, L ^a   Ferrari, R ^a   Van Gilst, W H ^a   Komajda, M ^a   Madeira, H ^a   Mercadier, J J ^a   Nieminen, M ^a   Poole Wilson, P A ^a   Rieger, G A J ^a   Ruzillo, W ^a   Swedberg, K ^a   Tavazzi, L ^a   more..

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EXERCISE; EXERCISE TEST; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART STROKE VOLUME; HEMODYNAMICS; PRIORITY JOURNAL; PROGNOSIS;

EXERCISE TEST; EXERCISE TOLERANCE; HEART FAILURE, CONGESTIVE; HUMANS; PROGNOSIS; TREATMENT OUTCOME;

EID: 0034944272     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2388     Document Type: Article

References (94)

1. Relationship between exertional symptoms and functional capacity in patients with heart failure
2. Cardiopulmonary exercise testing for evaluation of chronic heart failure
3. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure
4. -1 revisited
5. Short-term reproducibility of cardiopulmonary measurements during exercise testing in patients with severe chronic heart failure
6. Reproducibility of cardiopulmonary exercise testing in elderly patients with congestive heart failure
7. Reproducibility of symptom-limited oxygen consumption and anaerobic threshold within the scope of spiroergometric studies in patients with heart failure
8. Serial exercise testing and prognosis in selected patients considered for cardiac transplantation
9. Mechanisms of exercise intolerance in congestive heart failure
10. Cardiac and peripheral responses to exercise in patients with chronic heart failure
11. Exercise limitation in chronic heart failure; central role of the periphery
12. Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure. Effects of physical training
13. Skeletal muscle function at low work level as a model for daily activities in patients with chronic heart failure
14. Altered expression of myosin heavy chain in human skeletal muscle in chronic heart failure
15. Heart failure related myopathy. Clinical and pathophysiological insights
16. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure
17. Exercise intolerance in patients with chronic heart failure: Role of pulmonary diffusion limitation
18. Diaphragm strength in chronic heart failure
19. Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure
20. An experimental study of physical fitness of air force personnel
21. Exercise testing of patients with coronary heart disease
22. National survey of exercise stress testing facilities
23. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure
24. Comparison of treadmill and bicycle exercise in patients with chronic heart failure
25. Factors determining symptoms in heart failure: Comparison of fast and slow exercise tests
26. A comparative analysis of four protocols for maximal treadmill stress testing
27. Comparison of four exercise protocols using anaerobic threshold measurement of functional capacity in congestive heart failure
28. Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris
29. Comparison of the ramp versus standard exercise protocols
30. Optimizing the exercise protocol for cardiopulmonary assessment
31. Exercise standards: A statement for healthcare professionals from the American Heart Association Writing Group. Special Report
32. Optimizing the exercise test for pharmacological investigations
33. Comparison of treadmill and bicycle exercise in patients with chronic heart failure
34. The six-minute walk: A new measure of exercise capacity in patients with chronic heart failure
35. Validation of a simple mechanical accelerometer (pedometer) for the estimation of walking activity
36. Assessment of oxygen uptake during the 6-minute walk test in patients with heart failure: Preliminary experience with a portable device
37. The six-minute walk test predicts peak oxygen uptake and survival in patients with advance heart failure
38. Reproducibility of the six-minute walking test in chronic congestive heart failure patients: Practical implications
39. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction
40. Optimizing therapy for complex or refractory heart failure: A management algorithm
41. Guidelines for the diagnosis of heart failure
42. An integrated approach to the interpretation of cardiopulmonary exercise testing
43. Respiratory abnormalities: Exercise evaluation of the dyspneic patients
44. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: Advantages of a new specific activity scale
45. A brief self-administered questionnaire to determine function capacity (The Duke Activity Status Index)
46. A nomogram to predict exercise capacity from a specific activity questionnaire and clinical data
47. A specific activity questionnaire to measure the functional capacity of cardiac patients
48. Daily physical activity levels in congestive heart failure
49. Validation of a simple mechanical accelerometer (pedometer) for the estimation of walking activity
50. Effects of enalapril in heart failure: A double-blind study of effects in exercise performance, renal function, hormones, and metabolic state
51. How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind men
52. Is maximal exercise testing a useful method to evaluate treatment of moderate heart failure?
53. Exercise testing in heart failure
54. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure
55. Optimizing the exercise test for pharmacological investigations
56. Reproducibility of cardiopulmonary parameters during exercise in patients with chronic cardiac failure: The need for a preliminary test
57. How many exercise tests are needed to minimize the placebo effect of serial exercise testing in patients with chronic heart failure?
58. The reproducibility of hemodynamic, electrocardiographic, and gas exchange data during treadmill exercise in patients with stable angina pectoris
59. Exercise testing in angina pectoris: The importance of protocol design in clinical trials
60. What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity
61. Target heart failure populations for newer therapies
62. Natural history and patterns of current practice in heart failure
63. Heart failure in the 1990s: Evolution of a major public health problem in cardiovascular medicine
64. The Registry of the International Society for Heart and Lung Transplantation: Eleventh Official Report
65. Ejection fraction, peak oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepepinephrine as determinants of prognosis in heart failure
66. Long-term sequential changes in exercise capacity and chronotropic responsiveness after cardiac transplantation
67. Long-term cardiopulmonary exercise performance after heart transplantation
68. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy
69. 2 determination in chronic heart failure: Is it still of value?
70. Clinical, hemodynamic and cardiopulmonary exercise test determinants of survival in patient referred for evaluation of heart failure
71. The role of exercise and gas exchange measurement in the prognostic assessment of patients with heart failure
72. Optimal candidates for heart transplantation: Is 14 the magic number?
73. Peak exercise oxygen consumption in chronic heart failure: Toward efficient use in the individual patient
74. Role of maximal oxygen consumption in establishment of heart transplant candidacy for heart failure patients with intermediate exercise tolerance
75. Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure?
76. The 6-min walk and peak oxygen consumption in advanced heart failure: Aerobic capacity and survival
77. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy?
78. Dangerous curves. A perspective on exercise, lactate and the anaerobic threshold
79. Cardiopulmonary exercise testing identified low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation
80. Prognostic significance of oxygen uptake kinetics during low level exercise in patients with heart failure
81. Kinetics of oxygen consumption during and after exercise in patients with dilated cardiomyopathy
82. Exercise-related ventilatory abnormality and survival in congestive heart failure
83. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure
84. Ventilatory and heart rate responses to exercise
85. Coupling of hemodynamic measurements with oxygen consumption during exercise does not improve risk stratification in patients with heart failure
86. Use of cardiopulmonary monitoring in the prognostic assessment of ambulatory patients with chronic heart failure
87. Improvement in exercises capacity of candidates awaiting heart transplantation
88. Safety of graded symptom-limited exercise testing in patients with heart failure
89. ACC/AHA Guidelines for exercise testing: Executive summary